Clinical covariates that improve surgical risk prediction and guide targeted prehabilitation: an exploratory, retrospective cohort study of major colorectal cancer surgery patients evaluated with preoperative cardiopulmonary exercise testing.
CPET
Cardiopulmonary exercise testing
Colorectal cancer surgery
Functional capacity
Prehabilitation
Journal
Perioperative medicine (London, England)
ISSN: 2047-0525
Titre abrégé: Perioper Med (Lond)
Pays: England
ID NLM: 101609072
Informations de publication
Date de publication:
26 May 2022
26 May 2022
Historique:
received:
27
03
2021
accepted:
17
02
2022
entrez:
25
5
2022
pubmed:
26
5
2022
medline:
26
5
2022
Statut:
epublish
Résumé
Preoperative risk stratification is used to derive an optimal treatment plan for patients requiring cancer surgery. Patients with reversible risk factors are candidates for prehabilitation programmes. This pilot study explores the impact of preoperative covariates of comorbid disease (Charlson Co-morbidity Index), preoperative serum biomarkers, and traditional cardiopulmonary exercise testing (CPET)-derived parameters of functional capacity on postoperative outcomes after major colorectal cancer surgery. Consecutive patients who underwent CPET prior to colorectal cancer surgery over a 2-year period were identified and a minimum of 2-year postoperative follow-up was performed. Postoperative assessment included: Clavien-Dindo complication score, Comprehensive Complication Index, Days at Home within 90 days (DAH-90) after surgery, and overall survival. The Charlson Co-morbidity Index did not discriminate postoperative complications, or overall survival. In contrast, low preoperative haemoglobin, low albumin, or high neutrophil count were associated with postoperative complications and reduced overall survival. CPET-derived parameters predictive of postoperative complications, DAH-90, and reduced overall survival included measures of VCO Consideration of modifiable 'triple low' preoperative risk (anaemia, malnutrition, deconditioning) factors and inflammation will improve surgical risk prediction and guide prehabilitation. Gas exchange parameters that focus on VCO
Sections du résumé
BACKGROUND
BACKGROUND
Preoperative risk stratification is used to derive an optimal treatment plan for patients requiring cancer surgery. Patients with reversible risk factors are candidates for prehabilitation programmes. This pilot study explores the impact of preoperative covariates of comorbid disease (Charlson Co-morbidity Index), preoperative serum biomarkers, and traditional cardiopulmonary exercise testing (CPET)-derived parameters of functional capacity on postoperative outcomes after major colorectal cancer surgery.
METHODS
METHODS
Consecutive patients who underwent CPET prior to colorectal cancer surgery over a 2-year period were identified and a minimum of 2-year postoperative follow-up was performed. Postoperative assessment included: Clavien-Dindo complication score, Comprehensive Complication Index, Days at Home within 90 days (DAH-90) after surgery, and overall survival.
RESULTS
RESULTS
The Charlson Co-morbidity Index did not discriminate postoperative complications, or overall survival. In contrast, low preoperative haemoglobin, low albumin, or high neutrophil count were associated with postoperative complications and reduced overall survival. CPET-derived parameters predictive of postoperative complications, DAH-90, and reduced overall survival included measures of VCO
CONCLUSION
CONCLUSIONS
Consideration of modifiable 'triple low' preoperative risk (anaemia, malnutrition, deconditioning) factors and inflammation will improve surgical risk prediction and guide prehabilitation. Gas exchange parameters that focus on VCO
Identifiants
pubmed: 35614461
doi: 10.1186/s13741-022-00246-3
pii: 10.1186/s13741-022-00246-3
pmc: PMC9134693
doi:
Types de publication
Journal Article
Langues
eng
Pagination
20Informations de copyright
© 2022. The Author(s).
Références
J Natl Cancer Inst. 2014 May 29;106(6):dju124
pubmed: 24875653
Oncologist. 2011;16(1):112-20
pubmed: 21212429
Lancet Respir Med. 2015 Jan;3(1):33-41
pubmed: 25523407
Ann Surg. 2013 Jul;258(1):1-7
pubmed: 23728278
ESMO Open. 2018 Feb 14;3(2):e000302
pubmed: 29531839
N Engl J Med. 1999 Oct 28;341(18):1351-7
pubmed: 10536127
Cell Physiol Biochem. 2018;51(3):1237-1249
pubmed: 30481755
Br J Anaesth. 2018 Mar;120(3):484-500
pubmed: 29452805
JAMA. 2000 Sep 20;284(11):1392-8
pubmed: 10989401
Anesthesiology. 2013 Oct;119(4):959-81
pubmed: 24195875
Oncotarget. 2017 May 9;8(19):32356-32369
pubmed: 28404961
BMJ Open. 2015 Dec 16;5(12):e010006
pubmed: 26674506
Ann Surg. 2018 Jan;267(1):50-56
pubmed: 28489682
Am J Hematol. 2010 Jun;85(6):414-7
pubmed: 20513118
PLoS One. 2016 Feb 05;11(2):e0148076
pubmed: 26848761
Inflammation. 2011 Feb;34(1):29-35
pubmed: 20336357
Br J Anaesth. 2010 Apr;104(4):465-71
pubmed: 20190255
Circulation. 2003 Mar 4;107(8):1189-94
pubmed: 12615800
Eur J Appl Physiol Occup Physiol. 1989;58(8):879-83
pubmed: 2767070
Lancet. 2012 Sep 22;380(9847):1075-81
pubmed: 22998717
Anaesthesia. 2009 Aug;64(8):883-93
pubmed: 19604193
Ann Surg. 2017 Mar;265(3):539-546
pubmed: 27070934
Anesthesiol Clin. 2015 Mar;33(1):1-16
pubmed: 25701925
J Am Coll Surg. 2013 Nov;217(5):833-42.e1-3
pubmed: 24055383
Crit Care Med. 2005 Nov;33(11):2621-8
pubmed: 16276189
J Am Coll Cardiol. 2001 Dec;38(7):1980-7
pubmed: 11738304
J Thorac Cardiovasc Surg. 2001 Jun;121(6):1064-8
pubmed: 11385372
Br J Anaesth. 2016 May;116(5):586-9
pubmed: 27106961
Brain Behav Immun. 2018 Jan;67:47-53
pubmed: 28807718
Ann Surg Oncol. 2015 Dec;22(13):4117-23
pubmed: 25869228
PLoS One. 2019 Aug 21;14(8):e0221277
pubmed: 31433825
J Am Coll Cardiol. 1994 Nov 15;24(6):1529-35
pubmed: 7930286
Postgrad Med J. 2011 Aug;87(1030):542-9
pubmed: 21242576
Best Pract Res Clin Anaesthesiol. 2011 Sep;25(3):461-72
pubmed: 21925410
Dis Colon Rectum. 2018 Jan;61(1):124-138
pubmed: 29219922
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Nihon Kyobu Geka Gakkai Zasshi. 1994 Nov;42(11):2037-40
pubmed: 7836813
Oncotarget. 2017 Mar 21;8(12):20011-20024
pubmed: 28212553
Lancet. 2018 Jun 30;391(10140):2631-2640
pubmed: 30070222
Nat Rev Cancer. 2006 Jan;6(1):24-37
pubmed: 16397525
Am J Phys Med Rehabil. 2013 Aug;92(8):715-27
pubmed: 23756434
Bratisl Lek Listy. 2021;122(7):474-488
pubmed: 34161115
Ann Intern Med. 2000 Apr 4;132(7):552-5
pubmed: 10744592
Br J Anaesth. 2016 Feb;116(2):177-91
pubmed: 26787788
Braz J Phys Ther. 2013 Jan-Feb;17(1):69-76
pubmed: 23117650
Lancet Oncol. 2008 Jul;9(7):629-35
pubmed: 18539529
J Am Coll Surg. 2019 Jan;228(1):72-80
pubmed: 30359831
Dis Colon Rectum. 2018 Mar;61(3):400-409
pubmed: 29377872
PLoS One. 2014 Dec 05;9(12):e111526
pubmed: 25478898